Sanofi Add us as a preferred source on Google
🔄 Data last refreshed 2 months ago
🤝
Make a deal with Sanofi
👋 Unclaimed listing — auto-generated from public data; rates are estimates, not set by the creator. 🔒 Paid proposals held safely in escrow — released only when the work's approved.
This is an unclaimed, auto-generated listing. It was built only from Sanofi’s publicly available X information. Sanofi has not claimed, verified, or endorsed it, and is not affiliated with, sponsored by, or a partner of SocialDB — no partnership or endorsement is implied, and any prices shown are estimates, not set by the creator.
Followers
145.7K
Posts
7.4K
Following
215
Account age
17 yrs
💰 Suggested sponsorship rate
$816 – $1.3K / sponsored post
Estimated from audience size & typical reach — every deal is negotiable and held in SocialDB escrow.
🎁 Free analysisfor Sanofi
Known for
3.5K views
#NEWS: Our phase 3 results show our medicine met its primary and secondary endpoints in treatment-naïve infants with infantile-onset Pompe disease (IOPD). Read more: https://t.co/VOyUtc3ax4
2.4K views
Our Q2 2026 results are now available.
Read the full press release for detailed insights: https://t.co/ZijzaqKgmQ
#SanofiResults $SAN $SNY
2.2K views
#NEWS: The @EU_Commission has approved our medicine for the treatment of certain people with secondary progressive #MultipleSclerosis , reinforcing our commitment to advancing scientific innovation that address unmet patient needs.
Learn more ⬇️
https://t.co/cZ6YH5IPhM
2.1K views
Our Q1 2026 results are now available.
See the press release for more details: https://t.co/McL3v5nR1p
#SanofiResults $SAN $SNY
📊 Post performance
Recent posts · views
May 28latest
1.7K
Avg views / post
1.2K–2K
Typical post (views)
1.2%
Reach vs followers
82/100
Very consistent reach
Apr 2009
On X since
Half of recent posts land between 1.2K and 2K views (median 1.7K) — a dependable floor a sponsored post can count on.
🔥 Top post: #NEWS: Our phase 3 results show our medicine met its primary and · 3.5K views
📊 Activity & format
Posting cadence
1.2 / week
A lower-frequency account — each post lands with more weight.
Content mix
Mostly images
Recent: 2 video · 15 image · 0 text.
Follower / following
678×
Follows 215 back. A strong ratio — an audience that follows them, not a follow-for-follow network.
Recent posts
View on X ↗
🔥 Top post
#NEWS: Our phase 3 results show our medicine met its primary and secondary endpoints in treatment-naïve infants with infantile-onset Pompe disease (IOPD). Read more: https://t.co/VOyUtc3ax4
Our Q2 2026 results are now available.
Read the full press release for detailed insights: https://t.co/ZijzaqKgmQ
#SanofiResults $SAN $SNY
#NEWS: Update on our phase 3 program in moderate-to-severe #AtopicDermatitis.
Learn more ⬇️
https://t.co/Pp1lF0swiy
#NEWS: The Japan Ministry of Health, Labour and Welfare has approved the first oral, reversible BTK inhibitor to treat adults with immune thrombocytopenia (ITP) who are refractory to other treatments. Read more ⬇️: https://t.co/gynO8BFmZi
#NEWS: The @EU_Commission has approved our medicine for the treatment of certain people with secondary progressive #MultipleSclerosis , reinforcing our commitment to advancing scientific innovation that address unmet patient needs.
Learn …
Sanofi appoints Paulo Fontoura as Global Head of R&D Pharma, starting September 1, 2026.
With 25+ years in pharmaceutical innovation, he brings a track record of 60+ new molecular entities and 20+ FDA/EMA approvals.
Read more: https:…
▶
We're chasing the miracles of science to improve people's lives. Last week, the world saw exactly how.
2026 marked our 8th consecutive year at #VivaTech, and we came to show, not tell, with operational AI delivering real impact for patie…
The Ministry of Health, Labour and Welfare in Japan has approved our subcutaneous therapy in combination with approved standard-of-care regimens for the treatment of multiple myeloma. Read the full announcement here: https://t.co/y8bEfZ6Wt…
▶
What a start at #VivaTech! Visit us at Booth 1D01 through June 20 to experience how we’re reinventing AI across the value chain.
Learn more: https://t.co/ufbsOfGFA1
#Sanofi @VivaTech
We’re back at #VivaTech 2026, and we’re raising the bar on what AI can do for global health.
Visit us June 17 – 20 at Booth 1D01 to see how our teams are accelerating breakthroughs across everything from research and development to manuf…
The @US_FDA granted accelerated approval for a treatment for #Type1Diabetes. Learn more: https://t.co/T7dMsW67eA
#NEWS: Update on our phase 3 clinical study in chronic inflammatory demyelinating polyneuropathy (CIDP).
Learn more ⬇️
https://t.co/G12CzYjKyz
💡 Facts
🗓️Joined X in 2009 — 17 years ago.
👁️Averages 1.7K views per post.
📤Posts about 1.2× per week.
💬0.01% engagement rate.
🏅Earned the 100K Followers for passing 100K followers.
🕵️ Fake follower check
Estimated37/100
Low
Credibility score
66%
Mixed
Real audience
Medium
Fake-follower risk
High
Data confidence
- Est. 66% real, active audience · Medium fake-follower risk.
- Low engagement (~1.2% of followers engage each post) — a sign of an inflated or inactive audience.
- Organic base — far more followers than accounts it follows.
- Established account (17+ years old).
- 0.01% engagement — below the ~2.2% typical for this size.
Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.
About
An R&D driven, AI-powered biopharma company committed to improving lives and delivering compelling growth. Terms for interactions: http://bit.ly/sanofi-terms
📸 Gallery
🔀 Audience overlap
EstimatedEstimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.
Mahindra Group
17%
Collector and District Magistrate Puri
15%
NerdWallet
13%
ESET
12%
ベリル🌟Live2Dご依頼受付中！
12%
Don Cannon™
11%
More like this
Find more →
Frequently asked questions
How much does Sanofi charge for a sponsorship?
Sanofi hasn't published fixed prices yet. Send a proposal through SocialDB and agree terms directly — your payment is held in escrow until the work is approved.
How do I contact Sanofi for a brand deal or collaboration?
Send a paid deal or collab request right here on SocialDB — we notify Sanofi, and once they accept, your payment is held safely in escrow and released when the work is approved. You don't need to track down an email.
How many followers does Sanofi have?
Sanofi has 145,663 followers on X.
✉ Message Sanofi
Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.
- ✓ Message any influencer from their listing
- ✓ The influencer gets notified by email
- ✓ Manage every conversation in one inbox
Already Pro? Log in.
🎤 Event / appearance with Sanofi
Booking an event / appearance is a Pro feature. Upgrade to book Sanofi for an in-person or virtual appearance — payment held safely in escrow until the event is done.
- ✓ Book them for events, livestreams, panels & more
- ✓ Sanofi gets notified by email
- ✓ Fee held in escrow, released after the appearance
Already Pro? Log in.
🚧
Sanofi isn't on SocialDB yet
Sanofi hasn't claimed this listing yet, so they can't accept sponsorships, collabs or other deals here. The prices shown are estimates.
🚀
You're out of free requests this month
Free accounts get 5 per month. Go Pro for unlimited sponsor pitches, collab requests & sponsorship deals — plus featured placement, the Verified badge, free withdrawals and more.
Upgrade to Pro — $9.95/mo →Your free limit resets on the 1st of next month.